Literature DB >> 8000491

Comparison of measures of lead exposure, dose, and chelatable lead burden after provocative chelation in organolead workers.

B S Schwartz1, M P McGrail, W Stewart, T Pluth.   

Abstract

OBJECTIVES: To describe 6 h urinary lead excretion (6 h PbU) after 1 g intravenous ethylene diamine tetraacetic acid (EDTA) in organolead manufacturing workers with mixed exposure to organic and inorganic lead; to determine the predictors of lead excretion (PbU); and to determine the extent to which internal lead stores and ongoing external exposure govern blood concentrations of lead (PbB).
METHODS: A case series of 21 active workers were studied. Personal industrial hygiene data, grouped by 29 exposure zones, in combination with personal interviews about work location and times were used to derive several measures of recent and cumulative exposure to organic and inorganic lead. The average exposure intensities assigned to the 29 zones ranged from 4 to 119 micrograms/m3 (0.02-0.57 mumol/m3 as lead) for organic lead and from 1 to 56 micrograms/m3 (0.004-0.27 mumol/m3) for inorganic lead.
RESULTS: After controlling for age, 6 h PbU was significantly and positively correlated with summary measures of PbB--for example, lifetime peak PbB, time weighted PbB--and zinc protoporphyrin concentrations--for example, lifetime peak zinc protoporphyrin, time weighted zinc protoporphyrin--but not with measures of estimated external exposure--for example, duration of exposure and cumulative exposure to inorganic or organic lead. Among workers with higher chelatable lead burdens (6 h PbU > or = 212.4 micrograms (1.03 mumol) divided at the median), there was no apparent relation between recent inorganic lead exposure and PbB at the time of chelation. Among workers with lower chelatable lead burdens (6 h PbU < 212.4 micrograms (1.03 mumol) however, there was a significant relation between exposure and effect between recent exposure to inorganic lead and PbBs.
CONCLUSION: These findings are consistent with the concept of physiological dampening. The high chelatable lead burden, a source of internal exposure, dampens the effect of external exposure on PbBs. The data suggest that in organolead workers with high chelatable lead burdens, PbBs may be more influenced by internal lead stores than by variations in airborne exposure to organic and inorganic lead.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000491      PMCID: PMC1128075          DOI: 10.1136/oem.51.10.669

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  22 in total

1.  The body burden of lead: comparison of mathematical models for accumulation.

Authors:  A H Marcus
Journal:  Environ Res       Date:  1979-06       Impact factor: 6.498

2.  Lead in human tissues.

Authors:  S B Gross; E A Pfitzer; D W Yeager; R A Kehoe
Journal:  Toxicol Appl Pharmacol       Date:  1975-06       Impact factor: 4.219

3.  The treatment of tetraethyl lead poisoning.

Authors:  P R BOYD; I N HENDERSON; G WALKER
Journal:  Lancet       Date:  1957-01-26       Impact factor: 79.321

Review 4.  Organolead compounds: environmental health aspects.

Authors:  P Grandjean; T Nielsen
Journal:  Residue Rev       Date:  1979

5.  Microdetermination and dynamic aspects of in vivo alkyl lead compounds. II. Studies on the dynamic aspects of alkyl lead compounds in vivo.

Authors:  K Hayakawa
Journal:  Nihon Eiseigaku Zasshi       Date:  1972-02

6.  Distribution and excretion of triethyllead in rats.

Authors:  W Bolanowska
Journal:  Br J Ind Med       Date:  1968-07

7.  Tetraethyl lead poisoning from gasoline sniffing.

Authors:  R O Robinson
Journal:  JAMA       Date:  1978-09-22       Impact factor: 56.272

8.  Gasoline sniffing, lead poisoning, and myoclonus.

Authors:  K S Hansen; F R Sharp
Journal:  JAMA       Date:  1978-09-22       Impact factor: 56.272

9.  Tetramethyl lead absorption: a report of human exposure to a high level of tetramethyl lead.

Authors:  J Gething
Journal:  Br J Ind Med       Date:  1975-11

10.  Kinetic analysis of lead metabolism in healthy humans.

Authors:  M B Rabinowitz; G W Wetherill; J D Kopple
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.